SLC5A2 and hydrops fetalis: An interesting meta-analysis study compared the relative efficacy of sacubitril/valsartan, vericiguat, and SGLT2 inhibitors in patients with HFrEF and showed how the risk of HF hospitalization does not differ significantly between patients on SGLT2i or sacubitril/valsartan, while dapagliflozin is superior to vericiguat [30].